Our bioinformatics data showed higher Dkk3 expression in CAF than in CD133+ or in CD133- cancer cells, supporting the hypothesis that Dkk3 in cancer stromal cells might be involved in cancer progression. This evidence concerns the gene PROM1 and cancer.